22nd Century Group 获得 StockNews.com 的“卖出”评级，第三季度亏损，净利润率为负，股本回报率为负。 22nd Century Group receives "sell" rating from StockNews.com with Q3 loss, negative net margin, and negative return on equity.

22世纪集团(NASDAQ:XXII)是一家以烟草产品为重点的生物技术公司,从StockNews.com获得“销售”评级。 22nd Century Group (NASDAQ: XXII), a biotechnology firm focused on tobacco products, has received a "sell" rating from StockNews.com. 该公司报告,Q3每股损失0.36美元,负净差为275.12%,股票收益为380.39%。 The company reported a Q3 loss of $0.36 per share, with a negative net margin of 275.12% and a return on equity of -380.39%. 公司股价开盘时为0.34美元,市值为317万美元. Its stock opened at $0.34, with a market cap of $3.17 million. Anson Funds Management LP 在第一季度增加了 106.9% 的股份，而空头股数在 8 月份下降了 38%。 Anson Funds Management LP increased its stake by 106.9% in Q1, while short interest declined by 38% in August.